2) Dr. Yanagisawa: How Vitamin C Repairs DNA Damage

Transcription

2) Dr. Yanagisawa: How Vitamin C Repairs DNA Damage
Effect of Vitamin C and antioxidative nutrition on radiationinduced gene expression in
Fukushima nuclear plant workers
Atsuo Yanagisawa, M.D., Ph.D.
Japanese College of IV Therapy
1
!&#$%
!"#$%
There are many scientific studies
demonstrate protective effects of
Vitamin C upon radiation-induced
cellular injury .
I5J%K32-B3(%L%3;%-%/.02,*20.%->-3(;2%,=2,.(-+%.-43-:0(
-'./'.#/0.*/123/4156$('73$15$3+1-'.8.*/61
9./4#:1;#6/'(3*/.6<*#:1=>*+'(0.13*1?3$.1
@.$.383*&1#1?#6638.150()*/1(A1@#+3#<(*B1
!"#$%%
&'(#)'*%+,-,).,%/,012'*%3#**,4,%5%%
6"#7)0%8,*-9%+,-,).,%!#"2,%1)%:';')%%
<'$'$#=#%,=%'*>%:%?'01'=%?,.%CDED@ABCBDA9BA>%
!"#$%&'()*+, '%()*+,-.%/01,.%/+-(2%-**34,(2%
0**)..,4%3(%5666%3(%7-/-(8%9-:,(2;%1<0%1,.,%,=/0;,4%
20%<3><%40;,;%0?%.-43-:0(%4,@,+0/,4%;,@,.,%A0(,%
B-..01%?-3+).,C%-(4%2<,.,-D,.%)(4,.1,(2%;2,B%*,++%
2.-(;/+-(2-:0(8%E01,@,.C%2<,F%4,@,+0/,4%;,@,.,%GH%
4-B->,%132<%43-..<,-%-(4%A+,,43(>C%-(4%,@,(2)-++F%
43,4%?.0B%B)+:/+,%0.>-(%?-3+).,8%
T. Yamamoto et al.
U-B-B020%,2%-+8%7%V-43-2%V,;%"#5#WX5J5SXT5XY8
Fig. 1. Mouse survival after whole body radiation (A). Mice were irradiated at 6, 8, 10, 12, and 14 Gy. The
effect of boneM0);,%*0)+4%;).@3@,%+,;;%2<-(%2<-(%&%GF%1<0+,%A04F%3..-43-:0(%
marrow transplantation on mouse survival after radiation (B). Mice were irradiated at 10, 12,
NOPHQ8%P0(,%B-..01%2.-(;/+-(2-:0(%NPMRQ%"S%<%-D,.%3..-43-:0(%
and 14 Gy. Mice
received BMT 24 h after radiation. N = 12 in each group. *P < 0.01 vs. other groups.
.,;*),4%B3*,%.,*,3@3(>%+,;;%2<-(%5"%GF8%E01,@,.C%(0%B3*,%.,*,3@3(>%
5S%GFTOPH%;).@3@,4C%A,*-);,%0?%.-43-:0(T3(4)*,4%GH%;F(4.0B,8
Prevention of Radiation GI Syndrome by Ascorbic Acid
Fig. 3. The K32-B3(%L%FEGD10&H%&H+#>I11-;%0.-++F%-4B3(3;2,.,4%?0.%Z%4-F;C%
effect of treatment with ascorbic acid on mouse survival after radiation. The mice were irradiated at 14 Gy -(4%2<,(%2<,%B3*,%)(4,.1,(2%5S%GF%3..-43-:0(8%9.,2.,-2B,(2%
and received BMT 24 h after radiation. They received ascorbic acid p.o. for 3 days either before
or after radiation, or received distilled water only before radiation. The mice pretreated with ascorbic acid
132<%-;*0.A3*%-*34%B-.[,4+F%3B/.0@,4%.-43-:0(T3(4)*,4%
were also irradiated at 14 Gy without BMT. N = 12 in each group, *P < 0.01 vs other groups.
3(2,;:(-+%4-B->,C%2<,.,AF%.,;*)3(>%B3*,%.,*,3@3(>%OPH%-2%5S%
GF%3(%*0BA3(-:0(%132<%PMR8
5)/4('61(A1M#<(*#:1O.A.*6.1
?.+3$#:1S(::.&.1U1;'()*+11
=.:AN1O.A.*6.1P('$.13*1V#T#*1
$(00.*/.+13*1/4361#'<$:.L1 !
\O<,(%1,%)(4,.2-[,%2<,%.,;*),%0?%@3*:B;%?.0B%-%
.-43-:0(T*0(2-B3(-2,4%-.,-%]);2%-D,.%-%.-43-:0(%
-**34,(2%0.%2,..0.3;BC%32%3;%3B/0.2-(2%?0.%.,;*),%2,-B%
B,BA,.;%20%T'(0T/:>1/#%.1Q3/#03*1S10.-++F8^%
J*1?#'$41EKL1CDEEL1/4.1'.6$).1/.#01(A1M#<(*#:1=.:AN
O.A.*6.1P('$.1/((%1QJR5?JM1S124.*1/4.>12.'.113*1
/4.1P)%)6430#1M)$:.#'1-:#*/B1
12
I"J%K32-B3(%L%3;%-%/.02,*20.%->-3(;2%3(2,.(-+%.-43-:0(
Q3/#03*1S1#61#1@#+3(T'(/.$/('11
11111115&#3*6/1J(+3*.NEKE1J*1Q38(1
M#''#1Q@1./1#:B1V1M)$J?.+1EWWKXKYZ[K\N[YD
H(2.-T2,;:*)+-.%3(],*:0(%0?%H043(,T5Z5%4,*.,-;,4%;/,.B%
<,-4%;).@3@-+%3(%B3*,%%-(4%3;%[(01(%-;%-(%,=/,.3B,(2-+%
B04,+%0?%3(2,.(-+%.-43-:0(%3(]).F8%
9.,2.,-2B,(2%0?%3(2.-T2,;:*)+-.%3(],*:0(%0?%K32-B3(%L%%0.%
0.-+%3(2-[,%0?%K32-B3(%L%3(*.,-;,4%;/,.B%<,-4%;).@3@-+%-D,.%
2<,%3(],*:0(%0?%H043(,T5Z5%3(%B3*,8%
R<);C%@32-B3(%L%3;%-%.-430/.02,*20.%1<,(%.-430()*+34,;%-.,%
3(*0./0.-2,4%3(%2<,%A04F%-(4%4,+3@,.%2<,%40;,%3(%-%*<.0(3*%
?-;<30(8
IZJ%f.-+%3(2-[,%0?%@32-B3(%L%/.,@,(2%.-43-:0(T%
%%%%%%%3(4)*,4%ab'%4-B->,%3(%<)B-(;8%
]^.$/1(A1+3./1#*+183/#03*1S1(*1OM516/'#*+1
7'.#%#&.13*1A'.64:>N36(:#/.+14)0#*1243/.1
7:((+1$.::6B1
;'..*1?_91./1#:B1?)/#<(*[email protected].#'$41KE[FEWWYIWENEDC
P+004%;-B/+,;%1,.,%2-[,(%A,?0.,%-(4%5%<%-D,.%A.,-[?-;2%
132<%0.-+%3(>,;:0(%0?%@32-B3(%L%NZX%B>_[>Q8%%
`-B/+,;%1,.,%3BB,43-2,+F%3..-43-2,4%);3(>%-%L0A-+2TY#%
<02;/02%-(4%ab'%4-B->,%1-;%B,-;).,4%);3(>%2<,%c*0B,2c%
-;;-F8%%
K32-B3(%L%3(>,;:0(%;<01,4%-%;3>(3d*-(2%.,4)*:0(%3(%ab'%
4-B->,%4),%20%3..-43-:0(%-(4%32;%/,-[%,e,*2%1-;%S%<0).%
-D,.%3(2-[,%0?%@32-B3(%L8%%
V-43-:0(%3(]).F%*-(%A,%/.02,*2,4%%
AF%-(:T0=34-:@,%()2.3:0(;%%
•  f.-+%3(2-[,%0?%-+/<-T+3/03*%-*34%-(4%@32-B3(%g%
.,4)*,4%).3(-.F%.-430-*:@32F%-(4%0=34-:@,%
;2.,;;%3(%3..-43-2,4%*<3+4.,(%3(%L<,.(0AF+8%
•  R<,.,%-.,%()B,.0);%;*3,(:d*%.,/0.2;%-A0)2%
()2.3:0(%-;%-%.-430T/.02,*20.%;)*<%-;%K32-B3(%'C%
LC%gC%hC%%`,+,(3)BC%G+)2-2<30(,C%M,+-20(3(C%
/.0A30:*;C%V,;@,.-2.0+C%,2*8%
•  '(:T0=34-:@,%.,;,.@,%0?%2<,%A04F%3;%-%[,F%.0+,%
?0.%/.,@,(:(>%.-43-:0(%3(]).F8%
fi*3-+%`2-2,2B,(2%0?%7LHR%-A0)2%%
\g(@3.0(B,(2-+%.-430-*:@32F%-(4%<,-+2<^%%
%3;;),4%3(%M-.*<%"6C%"#558%
`('%3*&1;'()T1(A1R4.1=/#/.0.*/1
5/6)(1a#*#&36#2#1?BOB 1 1?#6#6431b2#7)L1?BOB1
")'/(*1]B1")'%6(*L1?BOB11 1"'#+A('+1=B1`..%6L1?BOB11
@(*#:+1_)**3*&4#%.L1?BOB1 1=/.8.*1_3$%.>L1-4BOB1
R4(0#619.8>L1?BOB1
It is our strongest recommendation that those
living in the effected areas regularly take
antioxidant supplements such as vitamin C to
counteract the negative consequences of longterm low dose radiation exposure as well as to
protect the health of coming generations.
a.8%V0(%E)((3(><-[,%%%%%% a.8%`2,@,%E3*[,F a.8%'2;)0%U-(->3;-1-
a.8%R<0B-;%g8%j,@F%%%%%%%a.8%P).20(%M8%P,.[;0(%%%a.8%P.-4?0.4%`8%O,,[;%%a.8M-;-;<3%k1-A)
7LHR%T%V,*0BB,(4-:0(%
-.(T:.124(14#8.1#1T(6637:.13*/.'*#:1#*+H('1
.c/.'*#:1'#+3#<(*1.cT(6)'.164():+1/#%.1#*<N
(c3+#<8.16)TT:.0.*/61/(10#3*/#3*1(T<0#:1#*<N
(c3+#<8.1'.6.'8.1(*1/4.3'1(2*17(+>B1
%%K32-B3(%L% % % % %%%%5TZ>%% % %ZTS%:B,;%-%4-F%
%%0.%j3/0;0B-+%K32-B3(%L%5T"%>% % % %213*,%-%4-F%
%%'+/<-T+3/03*%-*34 % %%%%5##TZ##%B> %213*,%-%4-F%
%%`,+,(3)B% % % % %%%%%%X#T"##l> % %213*,%-%4-F%
%%K32-B3(%g % % % %%%%5##T"##%B>% %213*,%-%4-F%
%%132<%02<,.%,;;,(:-+%@32-B3(;%-(4%B3(,.-+;8%
7LHR%.,*0BB,(4-:0(%?0.%/,0/+,%1<0%10.[;%-2%
.-43-:0(T*0(2-B3(-2,4%-.,-%3(%2<,%n)[3;<3B-%%
b)*+,-.%9+-(28%
N5Q%K32-B3(%L%"X>%38@8%A,?0.,%10.[3(>%-2%()*+,-.%/+-(28%
%%%%%%.-43-:0(T*0(2-B3(-2,4%-.,-8%%
%%%%%%%%`2,.3+,%1-2,.%%%% %
%"X#Bj%% %
%X#$%@32-B3(%L%%% %X#Bj%
%%%%%%%%"#$%M>T*<+0.34,%
%%%%%%XBj %%%%%%%%%%%5$%P5"%
%
%%%5Bj%
%%%%%%%%PT*0B/+,=%5##%%% %%%%%%%%%%%%%%5Bj %%%%%%%%%5#$%PY%%%
%
%%%5Bj%
%%%%%%%%"X$a,=/-(2<,(0+ %%%%%%5Bj%
N"Q%a-3+F%;)//+,B,(2;%-2%10.[%
%%j3/0;0B-+%K32-B3(%L% %%"%>%m % %2<.,,%:B,;%-%4-F%
%%'+/<-T+3/03*%-*34%
%%`,+,(3)B% % %
%%K32-B3(%g% % %
%Z##%B>%m % %213*,%-%4-F%
%"##%l>%%m % %213*,%-%4-F%
%"##%B>%m %% %213*,%-%4-F%
%%132<%02<,.%,;;,(:-+%@32-B3(;8%
b-B,+,;;%
n-*,+,;;%%
E,.0,;
Japanese College of
Intravenous Therapy
(JCIT)
We are 400 members: 379 physicians
12 dentists
9 veterinarians
More than 10 educational seminars every year.
IV Vitamin C, IV Lipoic acid, IV Chelation,
Myers’ Cocktail, Ukrain, Nutrition therapy, etc.
24
The 1st JCIT Symposium of ” IVC for Cancer Patients”
Oct 17, 2010, Tokyo, Japan
"#!
$%&'!()*+!,-.!/012!3'34'&!
567+758!%9'&!&*:7%;<&%('5=>'!
3':75*6!5%+8?6(*=%+!(%!!
()'!/*<*+'8'!57=@'+!*6%+A!!
()'!/012!8(*('3'+(B!!!
26
Effect of Vitamin C and antioxidative nutrition on radiationinduced gene expression in
Fukushima nuclear plant workers
- A pilot study
Atsuo YANAGISAWA, M.D., Ph.D. (1)
Michie IWATA, M.D., Ph.D. (2)
Shuichi AKIYAMA (3)
(1) Japanese College of IV Therapy
(2) Iwata Ladies Clinic,
(3) Gene Science Co, Ltd.
27
H(2.04)*:0(%
In the statement of Environmental Radioactivity and Health
issued in March 29, 2011, we strongly recommended that
People living in the effected areas should regularly take
antioxidant supplements such as vitamin C to counteract the
negative consequences of long-term low dose radiation
exposure as well as to protect the health of coming
generations. However, TEPCO, government and all medias
ignored our statement.
Recently, we examined cancer-related gene expression in 16
men who had worked at severe radiation environment at
Fukushima nuclear plant. We also confirmed the improvement
of cancer risk score by the supplementation of Vitamin C and
other anti-oxidative nutrition.
28
M,2<04;%N5Q%%`2)4F%;)A],*2;%
`)A],*2;J%
5Y%B,(%NZ"TX6%F.;8Q%1<0%10.[,4%XTY%1,,[;%-2%
.-43-:0(%*0(2-B3(-2,4%-.,-%0?%n)[);<3B-%b)*+,-.%
9+-(2%-D,.%M-.*<%5"C%"#558%
'++%;)A],*2;%1,.,%2,B/0.-.F%10.[,.%0?%;)AT;)A%
*0(2.-*20.%*0B/-(F%0?%Rg9Lf8%
O0.[%0/,.-:0(;%-2%*0(2-B3(-2,4%-.,-J%
%%TTo%L0++,*:(>%*0(2-B3(-2,4%1-2,.%
%%TTo%M,-;).3(>%.-43-:0(%+,@,+%3(%2<,%/+-(2%-.,-%
%%TTo%V,B0@-+%0?%4,A.3;%
%%TTo%f/,.-:0(%0?%<,-@F%B-*<3(,.F%
29
M,2<04;%N"Q%%%M,-;).,B,(2%
P+004%;-B/+,%1-;%0A2-3(,4%?,1%4-F;%-D,.%2<,%
10.[3(>%/,.3048%H(%S%10.[,.;C%A+004%1-;%0A2-3(,4%
-2%A,?0.,%-(4%-D,.%2<,%10.[3(>%/,.3048%%%
M,-;).,B,(2J%
N5Q%O<0+,%A+004%*0)(2;%-(4%A+004%*<,B3;2.F%
N"Q%9+-;B-%+,@,+;%0?%?.,,%ab'%
NZQ%Sp%*-(*,.%.,+-2,4%>,(,%,=/.,;;30(%
NSQ%L-+*)+-2,%\L-(*,.%V3;[%`*0.,^%
\L-(*,.%V3;[%`*0.,^%1-;%*-+*)+-2,4%);3(>%,q)-:0(%
?0.B,4%AF%2<,%+0>3;:*%-(-+F;3;%?.0B%2<,%@-+),%0?%
Sp%*-(*,.T.,+-2,4%>,(,%,=/.,;;30(;8%
30
M,2<04;%NZQ%%%%%H(2,.@,(:0(%
N5Q  H(2.-@,(0);%K32-B3(%L%"X>%/.,;*.3/:0(%%
%`2,.3+,%1-2,.%%%% %"X#Bj%%%%%%%%%%%%%5"8X$%M>`fS %XBj
%X#$%@32-B3(%L%%% %X#Bj%N"X>Q %%
%KTP5J%5"#B> % %KTP"J %%%%%"B>%% %KTPZ%J% %S#B>%%
%KTPXJ%%%"XSB>% %KTPYJ% %5"#B>% %KTP5"J%%%%5B>%
N"Q%a-3+F%0.-+%;)//+,B,(2;%
%% %jF/0;0B-+%K32-B3(%L%%%5%>% %
% %'+/<-T+3/03*%-*34 % %Z##%B>%
% %`,+,(3)B% % % % %"##%l>%%
%% %K32-B3(%g % % % %"##%B>%
%M)+:TK32-B3(; % % % %
%
%
%
%%
%
%%
%213*,%-%4-F%
%213*,%-%4-F%
%213*,%-%4-F%
%213*,%-%4-F%
%213*,%-%4-F%
31
Free DNA concentration (ng/mL plasma)
Free DNA Concentration
200
175
Cut-off value <25ng/mL
150
>25ng/mL
Healthy control 17% (n=400)
Cancer patients 38% (n=400)
125
100
75
50
25
0
32
a3;2.3A):0(%0?%L-(*,.%V3;[%`*0.,%0(%%
E,-+2<F%;)A],*2;%-(4%L-(*,.%9-:,(2;8
"#25
!J
■)'*6()H!8?4I'5(8
健常者
".20
!
■5*+5'&!<*='+(8
担がん患者
割
合 15
!
咁
%
咂
,#
10
,.!
!#!
5
0
!.
∼10
∼20
∼30
∼40 ∼50 ∼60 ∼70
リスク判定値(0∼100)
0*+5'&!C78D!E5%&'!F.;,..G
∼80
∼90 ∼100
33
9+-;B-%n.,,%ab'%-(4%L-(*,.%V3;[%`*0.,%%
3(%n)[);<3B-%O0.[,.;%
▲
Plasma Free DNA
Cancer Risk Score
ng/mL
■
■
"#!
!.
M!
●
KL!
!.
Cancer Risk Score is calculated from the value of 48 cancerrelated gene expression using logistic analysis.
34
ge,*2%0?%-(:T0=34-:@,%()2.3:0(-+%3(2,.@,(:0(%0(%n.,,%
ab'%-(4%L-(*,.%V3;[%`*0.,%3(%n)[);<3B-%O0.[,.;8%%
Cancer Risk Score
ng/mL
FreeDNA
"#!
KL!
!.
!.
Before
2M
NO.B.#
Before
2M
Five workers were treated with IVC twice a month and oral anti-oxidative
nutritional supplements. 35
ge,*2%0?%-(:T0=34-:@,%()2.3:0(%0(%n.,,%ab'%-(4%%
L-(*,.%V3;[%`*0.,%A,?0.,%-(4%-D,.%XTY%1,,[;%0?%%
()*+,-.%/+-(2%10.[%-2%n)[);<3B-8%
ng/mL
Cancer Risk Score
FreeDNA
KL!
"#!
!.
!.
Before
After work Before
After work Four workers took once i.v. Vitamin C (25g) therapy at before they went, and
continuously took anti-oxidative supplements during the working period. No
significant change was seen in both Free DNA and Cancer Risk Score.
36
L0(*+);30(%
(1)  We evaluated the effects of radiation exposure on cancer
related gene expression in 17 men who worked 5-6 weeks at
the radiation contaminated area of Fukushima nuclear plant.
(2)  After working, plasma free DNA was increased in 2 of 13
workers, and cancer risk score was increased in 3. After the
2 months intervention with intravenous Vitamin C and oral
anti-oxidative nutritional supplements, free DNA returned to
normal level and cancer risk score was significantly
decreased (p<0.05).
(3)  No significant change was seen in 4 workers who took once
i.v. Vitamin C at before working and continuous intake of
anti-oxidative supplements during the working period. (4)  Increase in cancer risk by radiation exposure can be
protected by anti-oxidative nutritional intervention.
Fukushima workers in the radiation contaminated area
should take anti-oxidative nutrition therapy immediately. 37
\f(+F%K32-B3(%L%-(4%02<,.%-(:T0=34-:@,%%
()2.3:0);%;)//+,B,(2;%*-(%;-@,%2<,%
/,0/+,r;%+3?,%?.0B%.-43-:0(%3(]).F8^%
T%7LHR%10.[3(>%>.0)/%
54 yrs. female, stomach cancer
3 yrs after IVC (58 yrs)
BW= 40 kg
MF%9.0/0;-+%
M-3(2-3(3(>%0/:B-+%-(:T0=34-:0(%.,;,.@,%AF%
2-[3(>%K32-B3(%L%-(4%02<,.%-(:T0=34-:@,%
()2.3:0(%3;%,;;,(:-+%?0.%*-(*,.%/.,@,(:0(%-(4%
2.,-2B,(2C%-(2T->3(>C%.-430T/.02,*:0(%-(4%
0/:B)B%<,-+2<8%
Thank you !
http://www. iv-therapy.jp
P"!

Similar documents